EUVIMEDEUVIMED entdecken
Crossref

International Reference Pricing in Congressional Bill H.R.3 and Its Potential Impact on the U.S. Biotech Ecosystem

Duane Schulthess

Medicine and Clinical Science · 2020

DOI: 10.33425/2690-5191.1028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicine and Clinical Science, 2020. Verfasst von Duane Schulthess. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Schulthess, D. (2020). International Reference Pricing in Congressional Bill H.R.3 and Its Potential Impact on the U.S. Biotech Ecosystem. Medicine and Clinical Science. https://doi.org/10.33425/2690-5191.1028

Vancouver

Schulthess D. International Reference Pricing in Congressional Bill H.R.3 and Its Potential Impact on the U.S. Biotech Ecosystem. Medicine and Clinical Science. 2020. doi:10.33425/2690-5191.1028

BibTeX
@article{Schulthess2020,
  author = {Schulthess, Duane},
  title = {International Reference Pricing in Congressional Bill H.R.3 and Its Potential Impact on the U.S. Biotech Ecosystem},
  journal = {Medicine and Clinical Science},
  year = {2020},
  doi = {10.33425/2690-5191.1028}
}
Kostenlos starten →